OneMedNet (ONMD) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
16 Sep, 2026Company overview and business model
Operates as a healthcare software company specializing in digital medical image management, exchange, and sharing, with a focus on regulatory-grade imaging Real World Data (iRWD) for life sciences, pharma, and AI markets.
Provides solutions that de-identify, curate, and deliver clinical imaging data from a federated network of over 1,400 healthcare sites, supporting research, regulatory submissions, and product development.
Transitioned from its BEAM image exchange platform to focus on iRWD, targeting pharmaceutical, device, and AI companies seeking high-quality, curated imaging data.
Business model includes fixed-fee contracts for iRWD data delivery and subscription-based revenue for legacy BEAM platform, with a shift toward data brokerage as the primary revenue stream.
Strategic partnerships and private placements have expanded its data network and capital base, supporting growth and innovation in the Real World Evidence market.
Financial performance and metrics
Reported net losses of $10.1 million in 2024 and $33.8 million in 2023, with an accumulated deficit of $101.6 million as of December 31, 2024.
Revenue for 2024 was $0.64 million, down 37% from 2023, driven by the planned discontinuation of the BEAM platform and a strategic shift to iRWD sales.
Gross margin was negative in both 2024 and Q1 2025, reflecting high costs relative to revenue during the transition period.
As of March 31, 2025, cash and cash equivalents were $0.1 million, with $0.8 million in Bitcoin holdings; liquidity remains a significant concern.
Auditor's report includes a going concern warning due to recurring losses, negative cash flows, and insufficient liquidity for the next 12 months.
Use of proceeds and capital allocation
Proceeds from warrant exercises (up to $139 million if fully exercised) are intended for working capital and general corporate purposes.
Recent private placements and PIPE financings have been used to purchase Bitcoin, settle liabilities, and fund operations.
Additional capital raises are planned to support ongoing operations and growth initiatives.
Latest events from OneMedNet
- All proposals, including director elections and a reverse stock split, were approved.ONMD
AGM 2026 - AI-driven platform delivers live, anonymized healthcare data and diversifies assets with Bitcoin.ONMD
Investor presentation - Healthcare imaging data firm registers major share and warrant resale amid financial strain.ONMD
Registration filing - Registering over 31M shares and warrants for issuance and resale amid ongoing losses and liquidity risk.ONMD
Registration filing - Registering 11.7M shares for resale amid rapid RWD growth, ongoing losses, and liquidity risks.ONMD
Registration filing - Revenue declined 37% and net loss improved, but liquidity and Nasdaq compliance risks persist.ONMD
Q4 2024 - Registering resale of 11.7M shares amid revenue growth but ongoing liquidity and going concern risks.ONMD
Registration filing - Q3 2024 revenue dropped 56% year-over-year, with ongoing liquidity and financing challenges.ONMD
Q3 2024 - Q2 2025 saw a 32% revenue drop but a $3.0M net profit from debt restructuring gains.ONMD
Q2 2025